338 related articles for article (PubMed ID: 17427234)
21. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.
Krutilkova V; Trkova M; Fleitz J; Gregor V; Novotna K; Krepelova A; Sumerauer D; Kodet R; Siruckova S; Plevova P; Bendova S; Hedvicakova P; Foreman NK; Sedlacek Z
Eur J Cancer; 2005 Jul; 41(11):1597-603. PubMed ID: 15925506
[TBL] [Abstract][Full Text] [Related]
22. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
23. [Germline mutations of the p53 gene].
Frebourg T
Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
[TBL] [Abstract][Full Text] [Related]
24. Complex replication error causes p53 mutation in a Li-Fraumeni family.
Strauss EA; Hosler MR; Herzog P; Salhany K; Louie R; Felix CA
Cancer Res; 1995 Aug; 55(15):3237-41. PubMed ID: 7614454
[TBL] [Abstract][Full Text] [Related]
25. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
[TBL] [Abstract][Full Text] [Related]
26. Unusual adrenal cortical tumor of unknown biologic potential: a nodule in a nodule in a nodule.
Ranganathan S; Lynshue K; Hunt JL; Kane T; Jaffe R
Pediatr Dev Pathol; 2005; 8(4):483-8. PubMed ID: 16010500
[TBL] [Abstract][Full Text] [Related]
27. Li-Fraumeni syndrome in a Malaysian kindred.
Ariffin H; Martel-Planche G; Daud SS; Ibrahim K; Hainaut P
Cancer Genet Cytogenet; 2008 Oct; 186(1):49-53. PubMed ID: 18786442
[TBL] [Abstract][Full Text] [Related]
28. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
Watanabe T; Vital A; Nobusawa S; Kleihues P; Ohgaki H
Acta Neuropathol; 2009 Jun; 117(6):653-6. PubMed ID: 19340432
[TBL] [Abstract][Full Text] [Related]
29. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
[TBL] [Abstract][Full Text] [Related]
30. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review.
Soussi T; Leblanc T; Baruchel A; Schaison G
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):33-6. PubMed ID: 8511038
[TBL] [Abstract][Full Text] [Related]
31. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
Tabori U; Shlien A; Baskin B; Levitt S; Ray P; Alon N; Hawkins C; Bouffet E; Pienkowska M; Lafay-Cousin L; Gozali A; Zhukova N; Shane L; Gonzalez I; Finlay J; Malkin D
J Clin Oncol; 2010 Apr; 28(12):1995-2001. PubMed ID: 20308654
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of the retinoblastoma gene in a familial adrenocortical carcinoma.
Warneford S; Townsend M; Rowe PB; Dalla-Pozza L; Symonds G
Cell Growth Differ; 1991 Sep; 2(9):439-45. PubMed ID: 1751410
[TBL] [Abstract][Full Text] [Related]
33. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
Gozali AE; Britt B; Shane L; Gonzalez I; Gilles F; McComb JG; Krieger MD; Lavey RS; Shlien A; Villablanca JG; Erdreich-Epstein A; Dhall G; Jubran R; Tabori U; Malkin D; Finlay JL
Pediatr Blood Cancer; 2012 Jun; 58(6):905-9. PubMed ID: 21990040
[TBL] [Abstract][Full Text] [Related]
34. Inheritance of R337H p53 gene mutation in children with sporadic adrenocortical tumor.
Sandrini F; Villani DP; Tucci S; Moreira AC; de Castro M; Elias LL
Horm Metab Res; 2005 Apr; 37(4):231-5. PubMed ID: 15952083
[TBL] [Abstract][Full Text] [Related]
35. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors.
Feitosa JADS; das Chagas PF; de Sousa GR; Queiroz RGP; Cruzeiro GAV; Tone LG; Borges KS; Valera ET
Mol Biol Rep; 2020 Aug; 47(8):6439-6443. PubMed ID: 32671623
[TBL] [Abstract][Full Text] [Related]
36. Germline p53 mutation presenting as synchronous tumors.
Cavalier ME; Davis MM; Croop JM
J Pediatr Hematol Oncol; 2005 Aug; 27(8):441-3. PubMed ID: 16096528
[TBL] [Abstract][Full Text] [Related]
37. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
Lee SB; Kim SH; Bell DW; Wahrer DC; Schiripo TA; Jorczak MM; Sgroi DC; Garber JE; Li FP; Nichols KE; Varley JM; Godwin AK; Shannon KM; Harlow E; Haber DA
Cancer Res; 2001 Nov; 61(22):8062-7. PubMed ID: 11719428
[TBL] [Abstract][Full Text] [Related]
38. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
[TBL] [Abstract][Full Text] [Related]
39. The first case of Li-Fraumeni syndrome in Bosnia and Herzegovina: case report.
Vranic S; Kapur L; Foco F; Bilalovic N; Hainaut P
Pathologica; 2006 Apr; 98(2):156-9. PubMed ID: 16929790
[TBL] [Abstract][Full Text] [Related]
40. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]